[1] |
Consensus statement on the multidisciplinary manage-ment of patients with recurrent and primary rectal can-cer beyond total mesorectal excision planes[J]. Br J Surg, 2013, 100(8): 1009-1014.
|
[2] |
Harbour R, Miller J. A new system for grading recom-mendations in evidence based guidelines[J]. BMJ, 2001, 323(7308): 334-336.
|
[3] |
Miner TJ, Jaques DP, Paty PB, et al. Symptom control in patients with locally recurrent rectal cancer[J]. Ann Surg Oncol, 2003, 10(1): 72-79.
|
[4] |
Malcolm FL, Adiamah A, Banerjea A, et al. Long-term health-related quality of life following colorectal cancer surgery: patient-reported outcomes in a remote follow-up population[J]. Colorectal Dis, 2021, 23(1): 213-225.
|
[5] |
Nolte S, Liegl G, Petersen MA, et al. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15, 386 persons across 13 European countries, Canada and the Unites States[J]. Eur J Cancer, 2019, 107: 153-163.
|
[6] |
Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer[J]. World J Surg, 2011, 35(4): 895-899.
|
[7] |
中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会结直肠肿瘤专业委员会腹腔镜专业委员会, 中华医学会外科学分会结直肠外科学组. 中国直肠癌侧方淋巴结转移诊疗专家共识(2019版) [J]. 中华胃肠外科杂志, 2019, 22(10): 901-912.
|
[8] |
Lu YY, Chen JH, Chien CR, et al. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis[J]. Int J Colorectal Dis, 2013, 28(8): 1039-1047.
|
[9] |
Kau T, Reinprecht P, Eicher W, et al. FDG PET/CT in the detection of recurrent rectal cancer[J]. Int Surg, 2009, 94(4): 315-324.
|
[10] |
Watson AJ, Lolohea S, Robertson GM, et al. The role of pos-itron emission tomography in the management of recur-rent colorectal cancer: a review[J]. Dis Colon Rectum, 2007, 50(1): 102-114.
|
[11] |
Plodeck V, Rahbari NN, Weitz J, et al. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences[J]. Eur Radiol, 2019, 29(1): 422-428.
|
[12] |
Matsuyama T, Yamauchi S, Masuda T, et al. Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients[J]. Int J Colorectal Dis, 2021, 36(6): 1243-1250.
|
[13] |
裴炜, 熊斌, 崔书中, 等. 结直肠癌腹膜转移预防和治疗腹腔用药中国专家共识(V2019) [J/CD]. 中华结直肠疾病电子杂志, 2019, 8(4): 329-335.
|
[14] |
Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer[J]. Dis Colon Rectum, 2005, 48(5): 929-937.
|
[15] |
Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability[J]. Dis Colon Rectum, 2004, 47(10): 1599-1606.
|
[16] |
张峻岭, 吴涛, 陈国卫, 等. 局部复发直肠癌手术根治性和预后的影响 因素分析[J]. 中华胃肠外科杂志, 2020, 23(5): 472-479.
|
[17] |
郭鹏, 王畅, 杨晓东, 等. 直肠癌骶前复发不同手术方式的临床疗效比较[J]. 中华胃肠外科杂志, 2020, 23(5): 466-471.
|
[18] |
中国医师协会外科医师分会结直肠外科医师委员会, 中国医师协会结直肠肿瘤专业委员会器官功能保护专业委员会, 中国医师协会肛肠医师分会, 等. 直肠癌骶前复发诊疗专家共识[J]. 中华胃肠外科杂志, 2020, 23(5): 438-444.
|
[19] |
Li Y, Wang J, Ma X, et al. A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer[J]. Int J Biol Sci, 2016, 12(8): 1022-1031.
|
[20] |
Kong JC, Soucisse M, Michael M, et al. Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and meta-analysis of oncological and operative outcomes[J]. Ann Surg Oncol, 2021, 28(12): 7476-7486.
|
[21] |
Denost Q, Frison E, Salut C, et al. A phase Ⅲ randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer-GRECCAR 15 trial protocol[J]. Colorectal Dis, 2021, 23(7): 1909-1918.
|
[22] |
CollaborativePelvEx. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study(PelvEx II)[J]. BJS Open, 2021, 5(3): zrab029.
|
[23] |
Fahy MR, Kelly ME, Power Foley M, et al. The role of intraoperative radiotherapy in advanced rectal cancer: a meta-analysis[J]. Colorectal Dis, 2021, 23(8): 1998-2006.
|
[24] |
Cameron MG, Kersten C, Vistad I, et al. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer-a systematic review[J]. Acta Oncol, 2014, 53(2): 164-173.
|
[25] |
Dijkstra EA, Mul V, Hemmer P, et al. Re-Irradiation in patients with recurrent rectal cancer is safe and feasible[J]. Ann Surg Oncol, 2021, 28(9): 5194-5204.
|
[26] |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)结直肠癌诊疗指南2022[M]. 北京: 人民卫生出版社, 2022.
|
[27] |
Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer [J]. N Engl J Med, 2022, 386(25): 2363-2376.
|
[28] |
Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review[J]. Dis Colon Rectum, 2013, 56(4): 519-531.
|
[29] |
Lee DJ, Sagar PM, Sadadcharam G, et al. Advances in surgical management for locally recurrent rectal cancer: How far have we come? [J]. World J Gastroenterol, 2017, 23(23): 4170-4180.
|
[30] |
Dozois EJ, Privitera A, Holubar SD, et al. High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved?[J]. J Surg Oncol, 2011, 103(2): 105-109.
|
[31] |
CollaborativePelvEx. Minimally invasive surgery tech-niques in pelvic exenteration: a systematic and meta-anal-ysis review[J]. Surg Endosc, 2018, 32(12): 4707-4715.
|
[32] |
Sun Y, Yang H, Zhang Z, et al. Fascial space priority approach for laparoscopic total pelvic exenteration in patients with locally advanced rectal cancer[J]. Surg Endosc, 2022, 36(8): 6331-6335.
|
[33] |
Kazi M, Kumar N, Rohila J, et al. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes [J]. BJS Open, 2021, 5(5): zrab074.
|
[34] |
Tang J, Liu J, Du B, et al. Short- and long-term outcomes of laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: a single-center propensity score matching analysis[J]. Tech Coloproctol, 2022.
|
[35] |
左帅, 陈贺凯, 郑利军, 等. 腹腔镜后盆腔脏器切除术治疗局部进展期直肠癌临床效果分析[J]. 结直肠肛门外科, 2020, 26(2): 148-153.
|
[36] |
Yang K, Cai L, Yao L, et al. Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases[J]. World J Surg Oncol, 2015, 13: 301.
|
[37] |
Nagasaki T, Akiyoshi T, Ueno M, et al. Laparoscopic salvage surgery for locally recurrent rectal cancer[J]. J Gastrointest Surg, 2014, 18(7): 1319-1326.
|
[38] |
CollaborativePelvEx. Palliative pelvic exenteration: A systematic review of patient-centered outcomes[J]. Eur J Surg Oncol, 2019, 45(10): 1787-1795.
|
[39] |
Chen YG, Liu YL, Jiang SX, et al. Adhesion pattern and prognosis studies of T4N0M0 colorectal cancer following en bloc multivisceral resection: evaluation of T4 subclassification[J]. Cell Biochem Biophys, 2011, 59(1): 1-6.
|
[40] |
王锡山. 结直肠癌联合脏器切除得与失及临床病理分期的思考[J]. 中国实用外科杂志, 2010, 30(12): 1002-1004.
|
[41] |
陈瑛罡, 刘彦龙, 刘正, 等. 原发ⅡC期结直肠癌患者炎性浸润与癌性浸润预后的比较研究[J]. 中华胃肠外科杂志, 2011, 14(4): 267-270.
|
[42] |
Kazi M, Rohila J, Kumar NA, et al. Urinary reconstruction following total pelvic exenteration for locally advanced rectal cancer: complications and factors affecting outcomes[J]. Langenbecks Arch Surg, 2021, 406(2): 329- 337.
|
[43] |
Johnson YL, West MA, Gould LE, et al. Empty pelvis syn-drome: asystematic review of reconstruction techniques and their associated complications[J]. Colorectal Dis, 2022, 24(1): 16-26.
|
[44] |
程文悦, 杨旭霞, 陈思诗, 等. 不同组织来源生物补片降解性能的比较研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2021, 15(1): 97-101.
|
[45] |
谢昆, 温冰, 翟伟, 等. 穿支皮瓣在修复会阴区肿瘤术后缺损中的应用[J]. 中华整形外科杂志, 2018, 34(9): 704-708.
|
[46] |
Bogner A, Fritzmann J, Müssle B, et al. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome[J]. Int J Colorectal Dis, 2021, 36(8): 1701-1710.
|
[47] |
Rausa E, Kelly ME, Bonavina L, et al. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer[J]. Colorectal Dis, 2017, 19(5): 430-436.
|
[48] |
Konstantinidis IT, Lee B, Trisal V, et al. National postoperative and oncologic outcomes after pelvic exenteration for T4b rectal cancer[J]. J Surg Oncol, 2020, 122(4): 739-744.
|
[49] |
CollaborativePelvEx. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration[J]. Ann Surg, 2019, 269(2): 315-321.
|
[50] |
Moghadamyeghaneh Z, Hwang GS, Hanna MH, et al. Surgical site infection impact of pelvic exenteration procedure[J]. J Surg Oncol, 2015, 112(5): 533-537.
|
[51] |
Rutledge FN, Smith JP, Wharton JT, et al. Pelvic exenteration: analysis of 296 patients[J]. Am J Obstet Gynecol, 1977, 129(8): 881-892.
|
[52] |
Jimenez RE, Shoup M, Cohen AM, et al. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer[J]. Dis Colon Rectum, 2003, 46(12): 1619-1625.
|
[53] |
Khan O, Patsouras D, Ravindraanandan M, et al. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events [J]. Eur Urol Focus, 2021, 7(3): 638-643.
|
[54] |
Hagemans J, Voogt E, Rothbarth J, et al. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit[J]. Eur J Surg Oncol, 2020, 46(6): 1160-1166.
|
[55] |
Venchiarutti RL, Solomon MJ, Koh CE, et al. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity[J]. Br J Surg, 2019, 106(10): 1393-1403.
|
[56] |
Radwan RW, Jones HG, Rawat N, et al. Determinants of survival following pelvic exenteration for primary rectal cancer[J]. Br J Surg, 2015, 102(10): 1278-1284.
|
[57] |
Kaur M, Joniau S, D'hoore A, et al. Pelvic exenterations for gynecological malignancies: a study of 36 cases[J]. Int J Gynecol Cancer, 2012, 22(5): 889-896.
|
[58] |
Sutton PA, Brown K, Ebrahimi N, et al. Long-term surgical complications following pelvic exenteration: operative management of the empty pelvis syndrome[J]. Colorectal Dis, 2022.
|
[59] |
Reinert T, Henriksen TV, Christensen E, et al. Analysis of plasma cell free DNA by ultradeep sequencing in patients with stages I to Ⅲ colorectal cancer[J]. JAMA Oncol, 2019, 5(8): 1124-1131.
|
[60] |
CollaborativePelvEx. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer[J]. Br J Surg, 2018, 105(6): 650-657.
|